Bromocriptine Mesylate Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 0 pharmaceutical companies such as . It is marketed under 0 brand names, including . Available in 0 different strengths, such as , and administered through 0 routes including .

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: Not available

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

Comprehensive global patent expiry timelines
Full patent family details and status updates

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

Comprehensive global patent expiry timelines
Full patent family details and status updates
Latest exclusivity data and extensions

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

Comprehensive global patent expiry timelines
Full patent family details and status updates

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"91956","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"31f535de357945f293b7","publication_number":"US8877708B2","cleaned_patent_number":"8877708","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-07","publication_date":"2014-11-04","legal_status":"Granted"} US8877708B2 Formulation 04 Nov, 2014 Granted 07 Jun, 2030
{"application_id":"91967","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"31f535de357945f293b7","publication_number":"US10688155B2","cleaned_patent_number":"10688155","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-07","publication_date":"2020-06-23","legal_status":"Granted"} US10688155B2 23 Jun, 2020 Granted 07 Jun, 2030
{"application_id":"91966","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"31f535de357945f293b7","publication_number":"US9895422B2","cleaned_patent_number":"9895422","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-07","publication_date":"2018-02-20","legal_status":"Granted"} US9895422B2 20 Feb, 2018 Granted 07 Jun, 2030
{"application_id":"91965","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"31f535de357945f293b7","publication_number":"US9352025B2","cleaned_patent_number":"9352025","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-07","publication_date":"2016-05-31","legal_status":"Granted"} US9352025B2 31 May, 2016 Granted 07 Jun, 2030
{"application_id":"91945","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"b10ff388844c4d1ea189","publication_number":"US8613947B2","cleaned_patent_number":"8613947","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-30","publication_date":"2013-12-24","legal_status":"Patented case"} US8613947B2 Formulation 24 Dec, 2013 Patented case 30 Apr, 2032
{"application_id":"91946","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"b10ff388844c4d1ea189","publication_number":"US9192576B2","cleaned_patent_number":"9192576","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-30","publication_date":"2015-11-24","legal_status":"Granted"} US9192576B2 Formulation 24 Nov, 2015 Granted 30 Apr, 2032
{"application_id":"91947","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"b10ff388844c4d1ea189","publication_number":"US9522117B2","cleaned_patent_number":"9522117","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-30","publication_date":"2016-12-20","legal_status":"Granted"} US9522117B2 Formulation 20 Dec, 2016 Granted 30 Apr, 2032
{"application_id":"91948","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"b10ff388844c4d1ea189","publication_number":"US9700555B2","cleaned_patent_number":"9700555","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-30","publication_date":"2017-07-11","legal_status":"Granted"} US9700555B2 Formulation 11 Jul, 2017 Granted 30 Apr, 2032
{"application_id":"91951","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"b10ff388844c4d1ea189","publication_number":"US10688094B2","cleaned_patent_number":"10688094","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-30","publication_date":"2020-06-23","legal_status":"Granted"} US10688094B2 23 Jun, 2020 Granted 30 Apr, 2032
{"application_id":"91949","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"b10ff388844c4d1ea189","publication_number":"US9993474B2","cleaned_patent_number":"9993474","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-30","publication_date":"2018-06-12","legal_status":"Granted"} US9993474B2 12 Jun, 2018 Granted 30 Apr, 2032
{"application_id":"91952","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"b10ff388844c4d1ea189","publication_number":"US11000522B2","cleaned_patent_number":"11000522","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-30","publication_date":"2021-05-11","legal_status":"Granted"} US11000522B2 11 May, 2021 Granted 30 Apr, 2032
{"application_id":"91953","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"b10ff388844c4d1ea189","publication_number":"US20210228576A1","cleaned_patent_number":"11666567","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-30","publication_date":"2023-06-06","legal_status":"Granted"} US11666567B2 06 Jun, 2023 Granted 30 Apr, 2032
{"application_id":"91928","ingredient":"BROMOCRIPTINE MESYLATE","trade_name":"CYCLOSET","family_id":"b10ff388844c4d1ea189","publication_number":"US8431155B1","cleaned_patent_number":"8431155","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-04-30","publication_date":"2013-04-30","legal_status":"Patented case"} US8431155B2 Formulation 30 Apr, 2013 Patented case 30 Apr, 2032

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Bromocriptine Mesylate

Access a comprehensive list of global suppliers
Get information on each supplier

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.